BIO-TECHNE Corp (TECH)

Biological Products, (No Diagnostic Substances)

Latest Price

$72.47

TTM P/E

105.03

Normalized P/E

36.19

Div Yield

0.44%

Book Value

13.33

P/B Ratio

5.44

Valuation metrics

EPS: $1.16

Book value / share: $13.51

Formula: √(22.5 × EPS × BVPS)

Graham Number

$18.78

74% downside

Norm. op. income: $237M (median of 7yr)

Tax rate: 16%

Discount rate: 10%

Growth assumption: zero (EPV is a no-growth value)

Earnings Power Value

$13.23

82% downside

Base FCF: $257M (median of recent 5yr)

Growth: 6%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$29.79

59% downside

EPS: $1.16

Target P/E: 36×

Formula: EPS × P/E

P/E Fair Value

$41.76

42% downside

100.0% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
BlackRock, Inc.	14.03M	$990.0M	8.99%	+1.76M	2026-06-30
FMR LLC	12.79M	$903.0M	8.20%	+4.89M	2026-06-30
Vanguard Capital Management LLC	10.22M	$721.0M	6.55%	+38.8K	2026-06-30
Goldman Sachs Group Inc	7.34M	$518.0M	4.70%	+5.40M	2026-06-30
Hbk Investments L P	6.83M	$482.0M	4.37%	--	2026-06-30
Vanguard Portfolio Management LLC	6.51M	$459.0M	4.17%	+26.0K	2026-06-30
Morgan Stanley	6.37M	$450.0M	4.08%	-2.16M	2026-06-30
State Street Corp	5.98M	$422.0M	3.83%	+112.0K	2026-06-30
Geode Capital Management, LLC	5.35M	$377.0M	3.43%	+239.0K	2026-06-30
Invesco Ltd.	4.99M	$352.0M	3.19%	+397.7K	2026-06-30